BioSpace News Archive

Business

Regeneron’s Q2 Looks Good, Driven by Eylea and Dupixent

Regeneron Pharmaceuticals reported its second-quarter financial results, citing quarterly total revenues of $1.608 billion, up 9 percent from the same quarter in 2017 of $1.470 billion.

August 2, 2018
·
3 min read
·
Mark Terry
Drug Development

Denali Shares Pop After Positive Parkinson’s Trial Data

Denali Therapeutics stock climbed 11 percent after the release of positive data from its Phase I clinical trial of DNL201 in Parkinson’s disease.

August 2, 2018
·
2 min read
·
Mark Terry
Drug Development

Epizyme Releases Q2 Financials and Efforts to Move Tazemetostat Forward

Cambridge, Massachusetts-based Epizyme emphasized its efforts to move tazemetostat back into clinical trials in its second-quarter financial report.

August 2, 2018
·
3 min read
·
Mark Terry
Business

European Medicines Agency Scales Back In Preparation for Brexit

As Britain’s “Brexit” from the European Union moves closer and closer, the European Medicines Agency (EMA), the equivalent to the U.S. Food and Drug Administration (FDA), temporary halted some of its activities in preparation.

August 2, 2018
·
2 min read
·
Mark Terry
Drug Development

Moderna Executive Heads to Oncorus as New President/CEO

Oncorus, a biotechnology company based in Cambridge, Massachusetts, announced that Theodore (Ted) T. Ashburn had been chosen as the company’s new president and chief executive officer.

August 2, 2018
·
2 min read
·
Mark Terry
Deals

BeiGene Sets Price for Hong Kong IPO, Rakes in Almost $1 Billion

BeiGene, a biotech company based in Beijing, China and Cambridge, Massachusetts, announced it priced its initial public offering (IPO) on the Hong Kong stock exchange.

August 2, 2018
·
2 min read
·
Mark Terry
Policy

Woman Sues Abilify Marketers Over Hefty Gambling Losses

A Minnesota woman, Denise Miley, is suing Bristol-Myers Squibb and Otsuka Pharmaeutical, alleging that their Abilify (aripiprazole) for depression and anxiety, caused a gambling impulse. Her suit isn’t the only one.

August 2, 2018
·
3 min read
·
Mark Terry
Drug Development

Karuna Pharma Closes on $42 Million Series A

Boston-based biotech company Karuna Pharmaceuticals completed a $42 million Series A financing. The round included the issuance of $22 million in shares upon conversion of debt into equity.

August 2, 2018
·
3 min read
·
Mark Terry
Business

Roche VP Leaves to Join Biotech Startup

IGM Biosciences, a privately-held biotech company located in Mountain View, California, announced that Daniel S. Chen will be the company’s new chief medical officer. Chen arrives from Genentech/Roche, where he was most recently vice president, Global Head of Cancer Immunotherapy.

August 2, 2018
·
2 min read
·
Mark Terry
Genetown

Cambridge Biotech Torque to Launch New T Cell Manufacturing Technique

Torque Therapeutics, a biotech company in Cambridge, Massachusetts, announced its high-efficiency T-cell manufacturing process called Slipstream.

August 2, 2018
·
3 min read
·
Mark Terry